Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis

Frontiers in Immunology- Switzerland

doi 10.3389/fimmu.2019.00745

Full Text

Abstract

Available in

Categories

Date

April 9, 2019

Authors

Mark Tarnopolsky

Ignacio Garcia-De La Torre

Heinrike Schmeling

Claire E. Barber

Marvin J. Fritzler

Publisher

Frontiers Media SA

Related search

Anti-Nt5c1a Autoantibodies for the Diagnosis and Study of the Pathogenesis of Sporadic Inclusion Body Myositis

Clinical and Experimental Neuroimmunology

English

Inclusion Body Myositis

Current Neurology and Neuroscience Reports

English

Inclusion Body Myositis

Practical Neurology

English

Inclusion Body Myositis

English

Sporadic Inclusion-Body Myositis and Hereditary Inclusion-Body Myopathies

Archives of Neurology

English

Treatment for Inclusion Body Myositis

English

CYLD Dysregulation in Pathogenesis of Sporadic Inclusion Body Myositis

Scientific Reports

Multidisciplinary

English

The Role of Quantitative Electromyography in Inclusion Body Myositis

Journal of Neurology, Neurosurgery and Psychiatry

English

Theories of the Pathogenesis of Inclusion Body Myositis

Current Rheumatology Reports

English